HALO logo

Halozyme Therapeutics, Inc. (HALO) Gross margin

annual gross margin:

77.30%+9.39%(+13.83%)
December 31, 2024

Summary

  • As of today (September 5, 2025), HALO annual gross profit margin is 77.30%, with the most recent change of +9.39% (+13.83%) on December 31, 2024.
  • During the last 3 years, HALO annual gross margin has fallen by -4.34% (-5.32%).
  • HALO annual gross margin is now -20.79% below its all-time high of 97.59%, reached on December 31, 2011.

Performance

1-year change

+13.83%

3-year change

-5.32%

5-year change

+0.7%

15-year change

-14.26%

HALO Gross margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

75.56%
HALO annual gross profit margin is higher than 75.56% of companies in Healthcare sector

Range

All-time high

97.59%
HALO annual gross profit margin is currently -20.79% below its historical high of 97.59%

3-year low

67.91%
HALO annual gross profit margin is currently +13.83% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
HALO previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
HALO next annual earnings announcement has not yet been scheduled

OtherHALOprofitability metrics

Annual revenue

$1.02B
HALO annual revenue is $1.02 billion

Annual gross profit

$784.86M
HALO annual gross profit is $784.86 million

annual operating margin

54.32%
HALO annual operating profit margin is 54.32%

annual net margin

43.74%
HALO annual net profit margin is 43.74%

quarterly gross margin:

80.31%+5.29%(+7.05%)
June 30, 2025

Summary

  • As of today (September 5, 2025), HALO quarterly gross profit margin is 80.31%, with the most recent change of +5.29% (+7.05%) on June 30, 2025.
  • Over the past year, HALO quarterly gross margin has increased by +5.11% (+6.80%).
  • HALO quarterly gross margin is now -18.80% below its all-time high of 98.91%, reached on September 30, 2011.

Performance

3-month change

+7.05%

1-year change

+6.8%

3-year change

+14.34%

5-year change

-10.38%

HALO quarterly gross margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

78.92%
HALO quarterly gross profit margin is higher than 78.92% of companies in Healthcare sector

Range

All-time high

98.91%
HALO quarterly gross profit margin is currently -18.80% below its historical high of 98.91%

3-year low

64.34%
HALO quarterly gross profit margin is currently +24.82% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
HALO previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
HALO next earnings announcement is scheduled for Oct 28, 2025

OtherHALOprofitability metrics

Quarterly revenue

$325.72M
HALO quarterly revenue is $325.72 million

quarterly gross profit

$261.60M
HALO quarterly gross profit is $261.60 million

quarterly operating margin

62.15%
HALO quarterly operating profit margin is 62.15%

Quarterly net margin

50.71%
HALO quarterly net profit margin is 50.71%

Gross margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

annual gross margin

77.30%
HALO annual gross profit margin is 77.30%

Annual gross profit

$784.86M
HALO annual gross profit is $784.86 million

Annual revenue

$1.02B
HALO annual revenue is $1.02 billion

HALO Gross margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.8%+6.8%
3 y3 years-5.3%+14.3%
5 y5 years+0.7%-10.4%

HALO Gross margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.3%+13.8%at high+24.8%
5 y5-year-7.8%+13.8%-12.2%+24.8%
alltimeall time-20.8%+175.0%-18.8%+115.1%

HALO Gross margin History

DateAnnualQuarterly
Jun 2025
-
80.31%(+7.1%)
Mar 2025
-
75.02%(-6.1%)
Dec 2024
77.30%(+13.8%)
79.93%(+4.0%)
Sep 2024
-
76.84%(+2.2%)
Jun 2024
-
75.20%(-1.7%)
Mar 2024
-
76.47%(+10.0%)
Dec 2023
67.91%(-6.1%)
69.54%(+6.6%)
Sep 2023
-
65.21%(-5.9%)
Jun 2023
-
69.28%(+2.9%)
Mar 2023
-
67.31%(-9.4%)
Dec 2022
72.36%(-11.4%)
74.28%(+15.4%)
Sep 2022
-
64.34%(-8.4%)
Jun 2022
-
70.24%(-18.7%)
Mar 2022
-
86.42%(+9.6%)
Dec 2021
81.64%(-2.6%)
78.84%(-6.1%)
Sep 2021
-
83.95%(+1.0%)
Jun 2021
-
83.13%(+4.5%)
Mar 2021
-
79.53%(+1.4%)
Dec 2020
83.79%(+9.2%)
78.41%(-14.3%)
Sep 2020
-
91.48%(+2.1%)
Jun 2020
-
89.61%(+16.1%)
Mar 2020
-
77.18%(+12.0%)
Dec 2019
76.76%(-17.8%)
68.91%(+33.3%)
Sep 2019
-
51.69%(-44.2%)
Jun 2019
-
92.65%(+0.9%)
Mar 2019
-
91.84%(+1.3%)
Dec 2018
93.33%(+3.5%)
90.67%(-7.1%)
Sep 2018
-
97.55%(-0.1%)
Jun 2018
-
97.63%(+8.3%)
Mar 2018
-
90.11%(-6.2%)
Dec 2017
90.16%(+16.5%)
96.05%(+10.5%)
Sep 2017
-
86.93%(+13.0%)
Jun 2017
-
76.92%(+3.3%)
Mar 2017
-
74.49%(-6.3%)
Dec 2016
77.36%(-1.3%)
79.48%(+11.4%)
Sep 2016
-
71.32%(-5.0%)
Jun 2016
-
75.08%(-8.1%)
Mar 2016
-
81.74%(-2.5%)
Dec 2015
78.35%(+12.2%)
83.86%(+19.4%)
Sep 2015
-
70.26%(-13.5%)
Jun 2015
-
81.23%(+24.6%)
Mar 2015
-
65.21%(-18.2%)
Dec 2014
69.83%
79.76%(+23.1%)
Sep 2014
-
64.80%(-4.4%)
Jun 2014
-
67.78%(+25.8%)
DateAnnualQuarterly
Mar 2014
-
53.87%(-24.8%)
Dec 2013
88.60%(-6.6%)
71.68%(-25.1%)
Sep 2013
-
95.74%(+5.1%)
Jun 2013
-
91.12%(-2.8%)
Mar 2013
-
93.76%(-2.0%)
Dec 2012
94.86%(-2.8%)
95.70%(+5.9%)
Sep 2012
-
90.39%(-4.5%)
Jun 2012
-
94.65%(-1.3%)
Mar 2012
-
95.85%(-118.0%)
Dec 2011
97.59%(+19.4%)
-531.08%(-636.9%)
Sep 2011
-
98.91%(+0.9%)
Jun 2011
-
97.99%(+2.6%)
Mar 2011
-
95.52%(+45.8%)
Dec 2010
81.70%(-6.3%)
65.50%(-26.5%)
Sep 2010
-
89.06%(+4.4%)
Jun 2010
-
85.28%(-3.0%)
Mar 2010
-
87.92%(-3.8%)
Dec 2009
87.16%(+3.5%)
91.39%(+8.2%)
Sep 2009
-
84.45%(+17.0%)
Jun 2009
-
72.19%(-18.0%)
Mar 2009
-
87.99%(+1.9%)
Dec 2008
84.25%(+7.3%)
86.35%(+3.7%)
Sep 2008
-
83.30%(+4.0%)
Jun 2008
-
80.09%(-6.1%)
Mar 2008
-
85.30%(+4.2%)
Dec 2007
78.50%(+156.2%)
81.86%(+5.7%)
Sep 2007
-
77.44%(+7.6%)
Jun 2007
-
71.97%(-9.9%)
Mar 2007
-
79.91%(+8.6%)
Dec 2006
30.64%(-129.7%)
73.56%(-570.3%)
Sep 2006
-
-15.64%(-140.3%)
Jun 2006
-
38.85%(-1155.7%)
Mar 2006
-
-3.68%(-87.4%)
Dec 2005
-103.07%(+1937.0%)
-29.16%(-73.7%)
Sep 2005
-
-110.94%(+39.7%)
Jun 2005
-
-79.43%(-84.4%)
Dec 2003
-5.06%(-111.7%)
-508.70%(-1880.5%)
Sep 2003
-
28.57%(-68.7%)
Jun 2003
-
91.25%(+27.7%)
Mar 2003
-
71.43%(-1734.6%)
Dec 2002
43.39%(+21.8%)
-4.37%(-105.6%)
Sep 2002
-
78.44%(+1429.0%)
Jun 2002
-
5.13%(-94.3%)
Mar 2002
-
90.31%
Dec 2001
35.63%
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual gross profit margin?
  • What is the all time high annual gross margin for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual gross margin year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly gross margin year-on-year change?

What is Halozyme Therapeutics, Inc. annual gross profit margin?

The current annual gross margin of HALO is 77.30%

What is the all time high annual gross margin for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual gross profit margin is 97.59%

What is Halozyme Therapeutics, Inc. annual gross margin year-on-year change?

Over the past year, HALO annual gross profit margin has changed by +9.39% (+13.83%)

What is Halozyme Therapeutics, Inc. quarterly gross profit margin?

The current quarterly gross margin of HALO is 80.31%

What is the all time high quarterly gross margin for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly gross profit margin is 98.91%

What is Halozyme Therapeutics, Inc. quarterly gross margin year-on-year change?

Over the past year, HALO quarterly gross profit margin has changed by +5.11% (+6.80%)
On this page